Cargando…

Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin

Twenty-four hours after administration, ketamine exerts rapid and robust antidepressant effects that are thought to be mediated by activation of the mechanistic target of rapamycin complex 1 (mTORC1). To test this hypothesis, depressed patients were pretreated with rapamycin, an mTORC1 inhibitor, pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdallah, Chadi G., Averill, Lynnette A., Gueorguieva, Ralitza, Goktas, Selin, Purohit, Prerana, Ranganathan, Mohini, Sherif, Mohamed, Ahn, Kyung-Heup, D’Souza, Deepak Cyril, Formica, Richard, Southwick, Steven M., Duman, Ronald S., Sanacora, Gerard, Krystal, John H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162891/ https://www.ncbi.nlm.nih.gov/pubmed/32092760 http://dx.doi.org/10.1038/s41386-020-0644-9

Ejemplares similares

Prefrontal Glutamate Neurotransmission in PTSD: A Novel Approach to Estimate Synaptic Strength in Vivo in Humans
por: Averill, Lynnette A., et al.
Publicado: (2022)

Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2
por: Luo, Yan, et al.
Publicado: (2015)

Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial
por: Abdallah, Chadi G., et al.
Publicado: (2022)

Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
por: Feldman, Morris E, et al.
Publicado: (2009)

Rapamycin Ameliorates Inflammation and Fibrosis in the Early Phase of Cirrhotic Portal Hypertension in Rats through Inhibition of mTORC1 but Not mTORC2
por: Wang, Weijie, et al.
Publicado: (2014)

A novel rapamycin analog is highly selective for mTORC1 in vivo
por: Schreiber, Katherine H., et al.
Publicado: (2019)

Effects of Nicotine on the Neurophysiological and Behavioral Effects of Ketamine in Humans
por: Mathalon, Daniel H., et al.
Publicado: (2014)

Speaker 4: John Krystal, USA
por: Krystal, John H., et al.
Publicado: (2016)

The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling
por: Delgoffe, Greg M., et al.
Publicado: (2011)

The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence
por: Ragnhildstveit, Anya, et al.
Publicado: (2023)

Combat Exposure Severity Is Associated With Reduced Cortical Thickness in Combat Veterans: A Preliminary Report
por: Averill, Lynnette A., et al.
Publicado: (2017)

Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2
por: Ye, Lan, et al.
Publicado: (2012)

Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2
por: Wang, Chen, et al.
Publicado: (2014)

17ß-Estradiol Regulates mTORC2 Sensitivity to Rapamycin in Adaptive Cardiac Remodeling
por: Kusch, Angelika, et al.
Publicado: (2015)

mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)

Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018)

Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases Prefrontal Global Connectivity in Depressed Patients
por: Abdallah, Chadi G., et al.
Publicado: (2018)

Phosphoproteomic Profiling of In Vivo Signaling in Liver by the Mammalian Target of Rapamycin Complex 1 (mTORC1)
por: Demirkan, Gokhan, et al.
Publicado: (2011)

Environmental signaling through the mechanistic target of rapamycin complex 1: mTORC1 goes nuclear
por: Workman, Jason J, et al.
Publicado: (2014)

Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins
por: Schreiber, Katherine H, et al.
Publicado: (2015)

Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
por: Chen, Long, et al.
Publicado: (2015)

The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling
por: Merhi, Ahmad, et al.
Publicado: (2017)

A New Journal: Addressing the Behavioral and Biological Effects of Chronic Stress
por: Abdallah, Chadi G, et al.
Publicado: (2017)

Mammalian Target of Rapamycin Complex 2 (mTORC2) Is a Critical Determinant of Bladder Cancer Invasion
por: Gupta, Sounak, et al.
Publicado: (2013)

mTORC1 inhibitor rapamycin and ER stressor tunicamycin induce differential patterns of ER-mitochondria coupling
por: Bravo-Sagua, Roberto, et al.
Publicado: (2016)

Rapamycin-induced miR-21 promotes mitochondrial homeostasis and adaptation in mTORC1 activated cells
por: Lam, Hilaire C., et al.
Publicado: (2017)

Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration
por: Razmara, Masoud, et al.
Publicado: (2018)

Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells
por: Séhédic, Delphine, et al.
Publicado: (2021)

Relationship of Resting Brain Hyperconnectivity and Schizophrenia-like Symptoms Produced by the NMDA receptor Antagonist Ketamine in Humans
por: Driesen, Naomi R., et al.
Publicado: (2013)

Salience Network Disruption in U.S. Army Soldiers With Posttraumatic Stress Disorder
por: Abdallah, Chadi G., et al.
Publicado: (2019)

mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation
por: Ding, Xiaolei, et al.
Publicado: (2016)

LPS Induces mTORC1 and mTORC2 Activation During Monocyte Adhesion
por: Ribeiro, Marcelle C., et al.
Publicado: (2018)

mTORC1 and mTORC2 differentially promote natural killer cell development
por: Yang, Chao, et al.
Publicado: (2018)

mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
por: Yang, Jin Young, et al.
Publicado: (2019)

Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2
por: Kosillo, Polina, et al.
Publicado: (2022)

Trajectories of relapse in randomized placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient level data meta-analysis
por: Gueorguieva, Ralitza, et al.
Publicado: (2017)

Rapamycin-insensitive mTORC1 activity controls eIF4E:4E-BP1 binding
por: Livingstone, Mark, et al.
Publicado: (2012)

The role of amino acid-induced mammalian target of rapamycin complex 1(mTORC1) signaling in insulin resistance
por: Yoon, Mee-Sup, et al.
Publicado: (2016)

Current Models of Mammalian Target of Rapamycin Complex 1 (mTORC1) Activation by Growth Factors and Amino Acids
por: Zheng, Xu, et al.
Publicado: (2014)

Regulation of Autophagy through TORC1 and mTORC1
por: Noda, Takeshi
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q0fcl7dmi0fej43jpkqnv3i68h